GMP production of a TAU oligomer inhibitor to enable clinical development for adrd
Ended Project Grant Awarded Last action
- Award ID
- R44AG066384
- Recipient
-
Oligomerix Inc. UEI MHB5HVJVAK87
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,171,769
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date
- Originally
- Place of performance
- New York, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $1,497,873 | |
| Amendment | $1,497,873 | |
| Amendment | $1,496,276 | |
| Amendment | $1,496,276 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $954,537 | |
| Amendment | $0 | |
| Original award | $1,228,934 |
Show all 12
Quick answers
Who received award R44AG066384?
R44AG066384 was awarded to Oligomerix Inc. by National Institute on Aging (National Institutes of Health) on September 30, 2019.
How much is award R44AG066384 worth?
$8,171,769 has been obligated on R44AG066384.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award